Alpha memo: resveratrol exercise training signal

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Resubmit only if the memo can identify a genuine directional discrepancy within the resveratrol+exercise literature (e.g., one paper showing harm or null result vs. another showing benefit), rather than constructing a false 'signal transfer' problem from two concordant positive results.
2. If the goal is cross-setting comparison, frame it honestly as 'two complementary positive findings in distinct models' rather than implying instability or non-transferability.
3. Specify which biological variables (species, disease model, endpoint tissue, molecular pathway) are actually being compared and why the boundary is scientifically meaningful.
4. Align the domain slug and title with the actual content.
5. Provide complete excerpts for both sources to enable verification.

Major issues

• The memo's central claim is that 'resveratrol/exercise does not carry one stable direction across the two receipts,' but both receipts actually report beneficial or synergistic effects of resveratrol + exercise; the memo manufactures a non-transferability signal that is not supported by the cited evidence.
• Receipt 1 (3xTg mice, cardiac/aortic endpoints) and Receipt 2 (diabetic rats, neuropathy/myopathy via SIRT1/NGF/GAP43) test different species, different disease models, and different endpoints. The memo frames this as a 'split' or 'bounded contrast,' but the receipts do not contradict each other—they simply address different questions. There is no within-source evidence of direction reversal.
• The title promises a 'resveratrol exercise training signal' but the memo's actual finding is meta-commentary about signal transferability, not a substantive research signal about resveratrol + exercise. The research question ('How far does the Receipt 1 signal transfer across the setting tested by Receipt 2?') is artificially constructed around two arbitrary papers rather than addressing a real scientific question.
• The 'falsifier' and 'next test' are generic matched-design placeholders that do not engage with the specific biology (e.g., SIRT1 pathway differences between cardiac and neuropathic endpoints, species differences in resveratrol metabolism).
• The memo acknowledges but does not actually investigate the limitation that 'this pair does not isolate whether species, population, dose, duration, modality, or endpoint class explains the split'—yet the entire conclusion rests on this unexamined boundary.

Minor issues

• The 'Why this is surprising' section overstates novelty; contrasting cardiac endpoints in AD mice vs. neuropathic endpoints in diabetic rats is an obvious apples-to-oranges comparison, not a genuine surprise.
• Domain slug 'ai_research' is mismatched with the actual content (pharmacology/exercise physiology).
• Receipt 1 excerpt is cut off mid-sentence, reducing verifiability.

Reviewer note

The memo's core problem is that it manufactures a 'non-transferability' signal from two receipts that are concordant—both report beneficial effects of resveratrol + exercise, just in different species, disease models, and endpoint tissues. The central claim that 'resveratrol/exercise does not carry one stable direction across the two receipts' is contradicted by the actual evidence, where Receipt 1 reports beneficial effects and Receipt 2 reports synergistic effects. There is no within-source signal of direction reversal. The memo's research question ('How far does the Receipt 1 signal transfer across the setting tested by Receipt 2?') is an artifact of pairing two arbitrary papers rather than a genuine scientific question. The memo acknowledges it cannot isolate which variable explains any apparent 'split,' yet still treats the boundary as meaningful. The domain slug mismatch and truncated excerpts further weaken the submission. This needs a scope reset or a different source bundle to produce a defensible alpha memo.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis